Product Overview

R‑Cinex 600 mg is a fixed‑dose combination tablet manufactured by Lupin Limited. Each strip contains three tablets that together deliver a daily dose of 300 mg isoniazid and 600 mg rifampicin, the two cornerstone drugs used in standard anti‑tuberculosis therapy. The product is classified as a Life‑Saving Drug and is indicated for the treatment of active pulmonary and extrapulmonary tuberculosis in adults and adolescents who can tolerate the recommended dosing. Because the two active ingredients are combined in a single tablet, the regimen improves adherence, reduces pill burden, and helps ensure that patients complete the full six‑month course required for cure.

What Is R‑Cinex 600 mg

R‑Cinex 600 mg pairs isoniazid and rifampicin in a fixed‑dose formulation. Isoniazid is a prodrug that is activated inside Mycobacterium tuberculosis by the bacterial enzyme KatG, leading to inhibition of mycolic‑acid synthesis, which is essential for the bacterial cell wall. Rifampicin binds directly to the bacterial DNA‑dependent RNA polymerase, blocking transcription and causing rapid bacterial death. The synergistic activity of these two agents makes the combination highly effective against both actively replicating and dormant bacilli, shortening the time needed for sputum conversion from positive to negative.

Uses and Clinical Benefits

The combination is used as part of a first‑line regimen for drug‑susceptible tuberculosis. In clinical trials, regimens that include R‑Cinex 600 mg together with pyrazinamide and ethambutol achieved cure rates exceeding 95 % when administered daily for six months. The fixed‑dose design simplifies dosing schedules, improves patient compliance, and reduces the likelihood of dosing errors that can occur when separate tablets are used. Moreover, the tablet’s formulation is stable at room temperature, making it suitable for use in settings where refrigeration is not available.

How It Works: Mechanism of Action

After oral administration, isoniazid is rapidly absorbed in the gastrointestinal tract and converted to its active form, which interferes with the synthesis of mycolic acids, crucial components of the mycobacterial cell wall. This disruption leads to bacterial lysis. Rifampicin penetrates well into granulomas and other tissues, where it binds to the RNA polymerase enzyme, preventing the formation of messenger RNA and thereby halting protein synthesis. The combined bactericidal effect accelerates the reduction of bacterial load in the lungs and other sites of infection, contributing to a faster clinical response.

Dosage Guidelines

For adult patients with normal hepatic function, the recommended dosing is one tablet daily, delivering 300 mg isoniazid and 600 mg rifampicin. The tablet should be taken with a full glass of water, preferably on an empty stomach (at least 30 minutes before or two hours after a meal) to maximize absorption of rifampicin. In patients with mild to moderate hepatic impairment, dose adjustments are generally not required, but liver function tests should be performed at baseline and periodically during therapy. For patients with severe hepatic disease, the medication should be used with caution, and alternative regimens may be considered. Pediatric dosing is weight‑based; the tablet is not recommended for children weighing less than 10 kg, and dosing for younger children should follow national guidelines that recommend separate formulations.

Side Effects and Adverse Reactions

Most patients tolerate R‑Cinex 600 mg well, but some may experience adverse effects. The most common side effects include hepatotoxicity (elevated liver enzymes), peripheral neuropathy, and gastrointestinal upset such as nausea or abdominal discomfort. Hepatic injury is the most serious concern; patients with pre‑existing liver disease or those taking other hepatotoxic drugs require close monitoring. Rifampicin can cause harmless orange discoloration of urine, sweat, and tears. Rarely, hypersensitivity reactions such as skin rash, fever, or severe allergic responses may occur and require discontinuation of the medication and appropriate medical management.

Warnings, Precautions, and Drug Interactions

R‑Cinex 600 mg is contraindicated in individuals with a known hypersensitivity to isoniazid, rifampicin, or any excipients in the formulation. Concomitant use with certain antiretroviral agents, particularly protease inhibitors, may lead to clinically significant drug‑drug interactions; dose adjustments or alternative regimens may be necessary. Rifampicin is a potent inducer of hepatic enzymes and can reduce the efficacy of oral contraceptives, certain anticoagulants, and some anti‑HIV medications. Patients should be advised to inform their healthcare provider of all medications they are taking, including over‑the‑counter products and herbal supplements. Pregnant or breastfeeding women should use the medication only if the potential benefit justifies the potential risk, and a clinician should be consulted before initiation.

Frequently Asked Questions

• What is the recommended treatment duration?

  The standard regimen for drug‑susceptible tuberculosis involves six months of daily R‑Cinex 600 mg, typically in combination with other first‑line agents such as pyrazinamide and ethambutol during the initial two months.

• Can the tablet be taken with food?

  It is generally recommended to take the tablet on an empty stomach to ensure optimal absorption of rifampicin; however, it may be taken with food if gastrointestinal tolerance is an issue, provided the timing is consistent.

• Is regular liver monitoring required?

  Yes. Baseline liver function tests should be obtained before starting therapy, and periodic testing is advised during treatment, especially for patients with pre‑existing liver conditions or those using other hepatotoxic medications.

• Does R‑Cinex interact with other medicines?

  Rifampicin induces hepatic enzymes and can diminish the effectiveness of hormonal contraceptives, certain anticoagulants, and some antiretrovirals. A thorough medication review is essential before initiating therapy to avoid therapeutic failure.

• Can the tablet be crushed or split?

  No. The tablet is formulated as a fixed‑dose combination and must be swallowed whole to maintain the intended dose ratio and to prevent dosing errors.

For additional scientific details and guideline recommendations, refer to reputable sources such as the National Institutes of Health, PubMed, and the U.S. Food and Drug Administration. More information on tuberculosis treatment protocols can be found at MedlinePlus and on the Wikipedia page for tuberculosis.

Related Products

• Pyzina 500 mg (Pyrazinamide)
• Ethambutol 200mg (Generic)
• Pyrazinamide 500 mg (Generic)
• Rofaday 500 mcg Tablet (Roflumilast)
• Nizonide (Nitazoxanide)
• Lupimeb 100 mg (Mebendazole)
• Nizonide 500 mg (Nitazoxanide)
• Nizonide DT 200mg (Nitazoxanide)
• Flugesic 100mg (Flupirtine)
• Abel 40 mg (Azilsartan Medoxomil)
• Cetil (Cefuroxime)
• Cetil 250mg (Cefuroxime)